PENUMBRA INC (PEN) Stock Price, Quote, News and Overview
NYSE:PEN - New York Stock Exchange, Inc. - US70975L1070 - Common Stock - Currency: USD
PEN Quote, Performance and Key Statistics
291.68
-11.44 (-3.77%)
The current stock price of PEN is 291.68 USD. In the past month the price increased by 6.54%. In the past year, price increased by 22.36%.
PEN Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 28.89 | 234.01B | ||
| ISRG | INTUITIVE SURGICAL INC | 80.74 | 211.07B | ||
| BSX | BOSTON SCIENTIFIC CORP | 41.63 | 154.00B | ||
| SYK | STRYKER CORP | 31.4 | 145.92B | ||
| MDT | MEDTRONIC PLC | 16.84 | 115.33B | ||
| BDX | BECTON DICKINSON AND CO | 16.35 | 65.30B | ||
| EW | EDWARDS LIFESCIENCES CORP | 27.98 | 43.23B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 20.29 | 41.62B | ||
| IDXX | IDEXX LABORATORIES INC | 40.25 | 37.07B | ||
| DXCM | DEXCOM INC | 53.81 | 34.68B | ||
| RMD | RESMED INC | 26.21 | 34.03B | ||
| PHG | KONINKLIJKE PHILIPS NVR- NY | 17.5 | 24.02B |
Related stock screener links
About PEN
Company Profile
Penumbra, Inc. engages in the design, development, manufacture, and marketing of innovative medical devices. The company is headquartered in Alameda, California and currently employs 4,200 full-time employees. The company went IPO on 2015-09-18. The firm designs, develops, manufactures, and markets products and has a portfolio that addresses challenging medical conditions in markets with unmet need. The company is focused on developing, manufacturing, and marketing products for use by specialist physicians and healthcare providers to drive improved clinical and health outcomes. The company is focused on developing and building its portfolio of products, including its thrombectomy, embolization, access, and immersive healthcare technologies. Common conditions that the Company focuses on Pulmonary Embolism, Deep Vein Thrombosis, Peripheral Arterial Occlusion, Ischemic Stroke, Acute Coronary Syndrome, Clot associated with Arteriovenous Graft or Fistula, Aneurysm, and Hemorrhagic Stroke. The firm sells its products to healthcare providers primarily through its direct sales organization in the United States, Europe, Canada and Australia, as well as through distributors in select international markets.
Company Info
PENUMBRA INC
One Penumbra Place
Alameda CALIFORNIA 94502 US
CEO: Adam Elsesser
Employees: 4200
Company Website: https://www.penumbrainc.com/
Investor Relations: https://www.penumbrainc.com/investors/
Phone: 15107483200
PENUMBRA INC / PEN FAQ
What is the stock price of PENUMBRA INC today?
The current stock price of PEN is 291.68 USD. The price decreased by -3.77% in the last trading session.
What is the ticker symbol for PENUMBRA INC stock?
The exchange symbol of PENUMBRA INC is PEN and it is listed on the New York Stock Exchange, Inc. exchange.
On which exchange is PEN stock listed?
PEN stock is listed on the New York Stock Exchange, Inc. exchange.
What is the price forecast or stock price prediction for PENUMBRA INC stock?
23 analysts have analysed PEN and the average price target is 271.44 USD. This implies a price decrease of -6.94% is expected in the next year compared to the current price of 291.68. Check the PENUMBRA INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is PENUMBRA INC worth?
PENUMBRA INC (PEN) has a market capitalization of 11.19B USD. This makes PEN a Large Cap stock.
How many employees does PENUMBRA INC have?
PENUMBRA INC (PEN) currently has 4200 employees.
What are the support and resistance levels for PENUMBRA INC (PEN) stock?
PENUMBRA INC (PEN) has a support level at 272.31. Check the full technical report for a detailed analysis of PEN support and resistance levels.
Is PENUMBRA INC (PEN) expected to grow?
The Revenue of PENUMBRA INC (PEN) is expected to grow by 14.3% in the next year. Check the estimates tab for more information on the PEN EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy PENUMBRA INC (PEN) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of PEN, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of PEN, evaluating the profitability, health, valuation and growth aspects
- PENUMBRA INC (PEN) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- PENUMBRA INC (PEN) Sales and EPS estimates to see what analysts future expectations are.
- PENUMBRA INC (PEN) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- PENUMBRA INC (PEN) Insider and Institutional Ownership to learn about the owners and their transactions.
- PENUMBRA INC (PEN) Stock Chart to make your own analysis
- PENUMBRA INC (PEN) Latest news and press-releases to stay up to date.
Does PENUMBRA INC (PEN) stock pay dividends?
PEN does not pay a dividend.
When does PENUMBRA INC (PEN) report earnings?
PENUMBRA INC (PEN) will report earnings on 2025-05-05, after the market close.
What is the Price/Earnings (PE) ratio of PENUMBRA INC (PEN)?
The PE ratio for PENUMBRA INC (PEN) is 101.63. This is based on the reported non-GAAP earnings per share of 2.87 and the current share price of 291.68 USD. Check the full fundamental report for a full analysis of the valuation metrics for PEN.
What is the Short Interest ratio of PENUMBRA INC (PEN) stock?
The outstanding short interest for PENUMBRA INC (PEN) is 3.89% of its float. Check the ownership tab for more information on the PEN short interest.
PEN Technical Analysis
ChartMill assigns a technical rating of 10 / 10 to PEN. When comparing the yearly performance of all stocks, PEN is one of the better performing stocks in the market, outperforming 86.3% of all stocks.
PEN Fundamental Analysis
ChartMill assigns a fundamental rating of 6 / 10 to PEN. PEN has an excellent financial health rating, but there are some minor concerns on its profitability.
PEN Financial Highlights
Over the last trailing twelve months PEN reported a non-GAAP Earnings per Share(EPS) of 2.87. The EPS increased by 37.32% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 2.97% | ||
| ROA | 2.34% | ||
| ROE | 3.13% | ||
| Debt/Equity | 0.02 |
PEN Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 82% to PEN. The Buy consensus is the average rating of analysts ratings from 23 analysts.
For the next year, analysts expect an EPS growth of 28.36% and a revenue growth 14.3% for PEN